Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Up 9.3% – Still a Buy?

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLXGet Free Report)’s stock price shot up 9.3% during mid-day trading on Monday . The stock traded as high as $17.29 and last traded at $17.29. 666 shares were traded during mid-day trading, a decline of 96% from the average session volume of 17,672 shares. The stock had previously closed at $15.82.

Analyst Ratings Changes

A number of analysts recently commented on the company. UBS Group assumed coverage on Telix Pharmaceuticals Limited American Depositary Shares in a research note on Friday, November 15th. They set a “buy” rating and a $21.00 price objective on the stock. William Blair upgraded Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a report on Tuesday, November 19th.

View Our Latest Analysis on TLX

Telix Pharmaceuticals Limited American Depositary Shares Price Performance

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

(Get Free Report)

Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.

Featured Articles

Receive News & Ratings for Telix Pharmaceuticals Limited American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Telix Pharmaceuticals Limited American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.